4.8 Article

Cancer-Cell-Specific Nuclear-Targeted Drug Delivery by Dual-Ligand-Modified Mesoporous Silica Nanoparticles

Journal

SMALL
Volume 11, Issue 44, Pages 5919-5926

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/smll.201501056

Keywords

-

Funding

  1. Australian Research Council (ARC) [DP130104459, DP140104062]
  2. Natural Sciences and Engineering Research Council of Canada (NSERC)

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available